A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004) için istatistikler
Toplam ziyaret
views | |
---|---|
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004) | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 0 |
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |